1. Age‐dependent prevalence of type 2 diabetes, cardiovascular risk profiles and use of diabetes drugs in Germany using health claims data. Issue 3 (27th December 2022) Authors: Otto, Thorsten; Diesing, Joanna; Borchert, Julia; Heitmann, Elke; C. Schloot, Nanette; Lebrec, Jeremie; Müller‐Wieland, Dirk; Haeckl, Dennis Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 3(2023) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months. Issue 12 (31st August 2022) Authors: Guerci, Bruno; Giorgino, Francesco; Sapin, Hélène; Boye, Kristina; Lebrec, Jérémie; Federici, Marco Orsini; Heitmann, Elke; Dib, Anne; Füchtenbusch, Martin; García‐Pérez, Luis‐Emilio Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 12(2022) Page Start: 2373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Weight loss in patients with type 2 diabetes receiving once‐weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post‐hoc analysis of the AWARD‐4 study across baseline body mass index subgroups. Issue 6 (15th March 2019) Authors: Fuechtenbusch, Martin; Aberle, Jens; Heitmann, Elke; Nicolay, Claudia; Jung, Heike Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 6(2019) Page Start: 1340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗